J
Juan Córdoba
Researcher at Autonomous University of Barcelona
Publications - 119
Citations - 12665
Juan Córdoba is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Hepatic encephalopathy & Cirrhosis. The author has an hindex of 48, co-authored 119 publications receiving 10883 citations. Previous affiliations of Juan Córdoba include Northwestern University & Carlos III Health Institute.
Papers
More filters
Journal ArticleDOI
Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis
Richard Moreau,Rajiv Jalan,Pere Ginès,Marco Pavesi,Paolo Angeli,Juan Córdoba,François Durand,Thierry Gustot,Faouzi Saliba,Marco Domenicali,Alexander L. Gerbes,Julia Wendon,Carlo Alessandria,Wim Laleman,Stefan Zeuzem,Jonel Trebicka,Mauro Bernardi,Vicente Arroyo +17 more
TL;DR: Diagnostic criteria for ACLF was established and showed that it is distinct from AD, based not only on the presence of organ failure(s) and high mortality rate but also on age, precipitating events, and systemic inflammation.
Journal ArticleDOI
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
Hendrik Vilstrup,Piero Amodio,Jasmohan S. Bajaj,Jasmohan S. Bajaj,Juan Córdoba,Peter Ferenci,Kevin D. Mullen,Karin Weissenborn,Philip Wong +8 more
TL;DR: The AASLD/EASL Practice Guideline Subcommittee on Hepatic Encephalopathy are: Jayant A. Talwalkar, Hari S. Conjeevaram, Michael Porayko, Raphael B. Merriman, Peter L. Jansen, Fabien Zoulim.
Journal ArticleDOI
HCV-related fibrosis progression following liver transplantation: increase in recent years
Marina Berenguer,Linda D. Ferrell,Jessica J. Watson,Martín Prieto,Michael Kim,Miguel Rayón,Juan Córdoba,Antonio Herola,Nancy L. Ascher,José Mir,Joaquín Berenguer,Teresa L. Wright +11 more
TL;DR: HCV-related disease progression is accelerated in immunocompromised compared to immunOCompetent patients, with a progressive increase in patients who have recently undergone liver transplantation.
Journal ArticleDOI
High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: Relationship with rejection episodes
Martín Prieto,Marina Berenguer,José M. Rayón,Juan Córdoba,Lidia Argüello,Domingo Carrasco,Antonio García-Herola,Vicente Olaso,Manuel de Juan,Gobernado M,José Mir,Joaquín Berenguer +11 more
TL;DR: HCV genotype 1b–infected liver recipients are at a high risk of developing graft cirrhosis in the first 4 to 5 years following transplantation, especially those with previous rejection episodes.
Journal ArticleDOI
EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure.
Julia Wendon,Juan Córdoba,Anil Dhawan,Fin Stolze Larsen,Michael Manns,Frederik Nevens,Didier Samuel,Kenneth J. Simpson,Ilan Yaron,Mauro Bernardi +9 more
TL;DR: The term acute liver failure (ALF) is frequently applied as a generic expression to describe patients presenting with or developing an acute episode of liver dysfunction, however, it refers to a highly specific and rare syndrome, characterised by an acute abnormality of liver blood tests in an individual without underlying chronic liver disease.